• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Skyepharma PLC

+ Add to Watchlist

SK8C:GR

4.145 EUR 0.052 1.24%

As of 15:20:15 ET on 12/23/2014.

Snapshot for Skyepharma PLC (SK8C)

Open: 4.251 Day's Range: 4.096 - 4.251 Volume: 0
Previous Close: 4.197 52wk Range: 1.135 - 4.986 1-Yr Rtn: +235.68%

Stock Chart for SK8C

No chart data available.
  • SK8C:GR 4.137
  • 1D
  • 1M
  • 1Y
4.197
Interactive SK8C Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SK8C

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 20.1523
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2014) 0.1610
Est. PEG Ratio -
Market Cap (M EUR) 434.45
Shares Outstanding (M) 104.81
30 Day Average Volume 678
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SK8C

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for SK8C

SkyePharma plc operates a group of companies that research, develop, manufacture and market prescription pharmaceutical products. The Group's products are available in topical, oral, injectable and inhalation form.

Peter William GrantChief Executive OfficerAndrew DerodraChief Financial Officer
John MurphySecretary/General Counsel
More Company Profile & Key Executives for SK8C

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil